KEAP1 and lung cancer: More recently, Fernandez-Cuesta et al. and Derks reported KEAP1 genetic alterations as a new uncovered molecular hallmark of LCNEC (lung cancer neuroendocrine) with adenocarcinoma-like features [30, 31].